PUBLISHED: OCT. 30, 2025 AT 3:07 PM CDT|UPDATED: 17 HOURS AGO
(GRAY NEWS) - A PHARMACEUTICAL COMPANY HAS ISSUED A VOLUNTARY RECALL FOR BLOOD PRESSURE MEDICATION OVER A REPORTED CANCER-CAUSING CHEMICAL BEING FOUND IN THE PRESCRIPTION DRUG. ACCORDING TO THE U.S. FOOD AND DRUG ADMINISTRATION, THE RECALL WAS ISSUED BY TEVA PHARMACEUTICALS AFTER THE PRESENCE OF A CARCINOGENIC COMPOUND WAS FOUND IN CERTAIN PRAZOSIN HYDROCHLORIDE CAPSULES.
